Overview

Safety Study of GCS-100 to Treat Chronic Kidney Disease

Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety of GCS-100 as a treatment for chronic kidney disease.
Phase:
Phase 1
Details
Lead Sponsor:
La Jolla Pharmaceutical Company